The Transplant Genomics brand, founded in 2013 (United States), from 90 sister brands and 2617 competing brands. Transplant Genomics is owned by EUROFINS SCIENTIFIC SE, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0014000MR3. The sector of Transplant Genomics is Medical Diagnostics & Research.

Share price and profitability of the share EUROFINS SCIENTIFIC SE (Transplant Genomics)

Buy EUROFINS SCIENTIFIC SE share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 59.08

Portfolio valuation
EUROFINS SCIENTIFIC SE (Transplant Genomics) over 5 years* EUR 93.27

Stock market history EUROFINS SCIENTIFIC SE (Transplant Genomics)